NERI nabs $18M NIH contract for pediatric circulatory support devices

Thursday, June 28, 2012 02:37 PM

New England Research Institutes (NERI), a privately held CRO that provides global, customized clinical trial solutions and registry services, has received an $18 million contract from the National Institutes of Health (NIH) for the PumpKIN Program for the development and clinical realization of novel pediatric circulatory support devices, such as ventricular assist devices (VADs) and extracorporeal membrane oxygenation devices (ECMOs).

The endeavor will be lead by Lynn Sleeper, ScD, and Sharon Tennstedt, PhD, and the contract signifies $105 million in total funding for pediatric clinical trials services at NERI.

Approximately 70% of medications prescribed to children have only been tested in adults. While there are FDA initiatives, such as Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA), aimed to close the gap, NERI has been working to address this imbalance for two decades, and is in the forefront of pediatric research.

NERI provides clinical trial and registry services for pediatric indications using drug or device interventions, with record growth. Approximately one-half of all NERI clinical trials include pediatric subjects encompassing over 22,000 subjects across 490 U.S. and international research sites. NERI also develops tools to educate and inform parents, clinicians, researchers and children about clinical research. In collaboration with National Heart, Lung, and Blood Institute (NHLBI), NERI developed a website, documentary film, social media presence and tools for clinics on children and clinical studies.  

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs